John P Moppett

15PUBLICATIONS
52CO-AUTHORS
Haematological tumoursInfant and child healthRisk policyCancer therapy (excl. chemotherapy and radiation therapy)Genetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 01, 2026
EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

|Feb 23, 2026
100 years of childhood acute lymphoblastic leukaemia in the UK.

Helen Lane, John Moppett

|Sep 10, 2025
Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision-making for blood transfusion.

Michael F Murphy, Damien Carson, Anwen Davies

|Apr 16, 2025
Expression and treatment of ROR1+ cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia.

Paraskevi Diamanti, Bethan K Bailey, Obinna E Iheanacho

|Apr 07, 2025
High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011.

Amy A Kirkwood, Nicholas Goulden, John Moppett

|Aug 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.

Teena Bhatla, Laura E Hogan, David T Teachey

Pageof 3

Frequent Collaborators

6 joint publications

Anthony V Moorman

4 joint publications

Sujith Samarasinghe

4 joint publications

Ajay Vora

4 joint publications

David O'Connor